Skip to main content
. 2020 Nov 25;24(1):52–68. doi: 10.1298/ptr.E10060

Table 2.

Items agreed to be essential (> 70% of participants said they were “essential”)

item Round 1
%
Round 2
%
Round 3
%
AUS-NZ UK
AUS-NZ: Australia and New Zealand, UK: the United Kingdom, *: Essential, NRC: did not reach consensus, NE: not essential, N/A: not available
ECG: electrocardiogram, PiCCO: pulse contour cardiac output, CO: cardiac output, CI: cardiac index, SVV: stroke volume variation,
SVRI: systemic vascular resistance index, PAP: pulmonary artery pressure, ECMO: extracorporeal membrane oxygenation, CPAP: continuous positive airway pressure, PEEP: positive end expiratory pressure, EPAP: expiratory positive airway pressure, PS: pressure support, IPAP: Inspiratory Positive Airway Pressure, SIMV: synchronised intermittent mandatory ventilation, STEMI: ST elevation myocardial infarction, NSTEMI: non-ST elevation myocardial infarction, VAP: ventilator-associated pneumonia, MODS: multiple organ dysfunction syndrome, COPD: chronic obstructive pulmonary disease, PVC: premature ventricular contraction, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, FEV1: forced expiratory volume in one second, FVC: forced vital capacity, CAM-ICU: confusion assessment method for the intensive care unit, CT: computed tomography, MRI: magnetic resonance imaging, ASIA: American Spinal Cord Injury Association, HCO3: bicarbonate, PaCO2: partial pressure of arterial carbon dioxide,
PaO2: partial pressure of arterial oxygen, SPO2: peripheral capillary oxygen saturation, SaO2: arterial oxygen saturation, pH: potential of hydrogen, SvO2: mixed venous oxygen saturation, FiO2: fraction of inspired oxygen
ACBT: active cycle of breathing technique, FET: forced expiratory technique, MRC: Medical Research Council, 6MWT: 6-minute walk test, EQ-5D: EuroQol 5 Dimension, AQoL: Assessment of Quality of Life
A physiotherapist is aware or has knowledge of
 Key literature that guides evidence-based physiotherapy practice in critical care settings
  Key literature that guides evidence-based physiotherapy practice in critical care settings 100 * NRC
 The actions and implications for physiotherapy of the following medications
  Analgesia 93 * N/A
  Anti-arrhythmics (e.g. amiodarone, digoxin) 96 * *
  Anti-hypertensives (e.g. beta-blockers, hydralazine) 98 * *
  Bronchodilators 89 * *
  Calcium channel blockers 87 NRC NE
  Sedation and neuromuscular paralyzing agents 100 * *
  Vasopressors/inotropes (e.g. dobutamine, milrinone, adrenaline, dopamine, noradrenaline) 100 * *
 Methods for advanced hemodynamic monitoring, can interpret the measurements and understands the implications for physiotherapy of
  Implanted or external pacemakers, and determine the presence of pacing on ECG 96 * NRC
  PiCCO measurements (e.g. CO, CI, SVV, SVRI etc.) 83 NE NE
  Pulmonary arterial catheter measurements (e.g. CO, CI, SVRI, PAP, etc.) 85 NE NE
A physiotherapist can understand
 Equipment (including recognition of equipment), can use/safely apply or handle equipment, understands the implications for physiotherapy of
  Arterial lines 100 * *
  Central venous catheters 98 * *
  ECMO 74 NE NE
  Endotracheal tubes and tracheostomy 100 * *
  Indwelling urinary catheters 91 * *
  Intercostal catheters 100 * *
  Intra-aortic balloon pump 89 NRC NE
  Intracranial pressure (ICP) monitors and extra-ventricular drains (EVD) 91 * NE
  Nasogastric tubes 98 * *
  Oxygen therapy devices 100 * *
  Vascath/hemodialysis/continuous veno-venous hemodiafiltration 94 * *
  Wound drains 100 * *
 The key principles of providing the following differing modes of mechanical/assisted ventilation including
  Airway Pressure Release Ventilation (APRV) 76 NE NE
  Assist-control 98 * NRC
  BiLevel 83 * *
  CPAP 98 * *
  PEEP/EPAP 100 * *
  Pressure-regulated Volume Control (PRVC) 81 * N/A
  PS/IPAP 100 * *
  SIMV (Volume) / (Pressure) 93 * *
  Weaning protocols 96 * NRC
 Pathophysiology and presenting features, likely medical management and implications for physiotherapy for a range of conditions including
  Acute coronary syndrome (e.g. angina, STEMI, NSTEMI) 100 * *
  Acute lung injury/acute respiratory distress syndrome (ARDS) 98 * *
  Burns (cutaneous/inhalational) 81 NRC NE
  Chest trauma 93 * *
  Community acquired/nosocomial/hospital-acquired pneumonia (including VAP) 100 * *
  Guillain-Barre Syndrome 76 * *
  Heart failure 100 * *
  Hepatitis 72 NRC NE
  ICU-acquired weakness (ICU-AW) 100 * *
  Immunocompromise 65 85 * *
  Intracerebral hemorrhage/Subarachnoid hemorrhage 100 * *
  Metabolic/electrolyte disturbances 98 * NRC
  Multi-organ failure/MODS 94 * *
  Multi-trauma 93 * NRC
  Obstructive respiratory disease (e.g. asthma, COPD) 100 * *
  Pancreatitis 76 * NRC
  Pleural effusion 98 * *
  Post-abdominal surgery 98 * *
  Post-cardiac surgery 94 * NRC
  Post-surgery other (e.g. orthopaedic, vascular) 94 * N/A
  Post-thoracic surgery 100 * NRC
  Renal failure (acute and chronic) 100 * *
  Respiratory failure (Type I and II) 100 * *
  Restrictive respiratory disease (e.g. pulmonary fibrosis, kyphoscoliosis) 98 * *
  Shock (cardiogenic) 98 * *
  Shock (septic) 94 * *
  Spinal cord injury 96 * *
  Suppurative lung disease (e.g. cystic fibrosis, bronchiectasis) 74 * *
  Systemic inflammatory response syndrome (SIRS) 89 * *
  Thromboembolic disease (e.g. deep vein thrombosis, pulmonary embolus) 100 * *
  Thrombotic cerebrovascular accident 96 * N/A
  Traumatic brain injury 94 * *
A physiotherapist can accurately/independently (assess and) interpret
 Readings from clinical monitoring including
  Advanced ECGs (i.e. conduction block, 12-lead ECG) 80 NE NRC
  Basic ECGs (i.e. sinus rhythm/tachycardia/bradycardia, atrial fibrillation, atrial flutter, ventricular tachycardia, ventricular fibrillation, asystole, PVCs) 98 * *
  Blood pressure (systolic, diastolic, and mean arterial blood pressure) 100 * *
  Body temperature 100 * *
  Central venous pressure 94 * NRC
  End tidal carbon dioxide 83 * *
  Fluid intake and output 96 * *
  Heart rate 100 * *
  Nutritional status including feed administration, volume and type 85 NE NE
  SpO2/Pulse oximetry 100 * *
 Findings from laboratory investigations including
  Albumin 94 NE NE
  Blood glucose levels 96 * *
  C-reactive protein (CRP) 100 NRC *
  Creatinine kinase (CK) 98 NRC NE
  Hematocrit 83 NE NE
  Hemoglobin 100 * *
  Liver function tests (e.g. ALT, LDH, Bilirubin) 93 NE NE
  Neutrophil counts 80 NRC NE
  Platelets, APTT (activated partial thromboplastin time), INR (international normalized ratio) 87 * *
  Renal function tests (e.g. urea, creatinine) 93 * NRC
  Respiratory function tests (e.g. FEV1, FVC etc.) 98 * NRC
  Troponin 76 * *
  White cell count (WCC) 98 * *
 Findings from imaging investigations (excluding the imaging report) including
  Chest radiographs (CXR) 94 * *
  CT - Brain imaging 74 NE NE
  CT - Chest imaging 81 NE NE
  MRI - Brain 74 NE NE
  Skeletal X-rays 81 NRC NE
  Ultrasound - Chest 74 NE NE
 Results from neurological equipment/examinations and functional tests including
  Ability to interpret a delirium assessment (e.g. the CAM-ICU) 96 NRC N/A
  Ability to perform a delirium assessment (e.g. the CAM-ICU) 83 NE NE
  An ability to interpret a Glasgow Coma Score (GCS) 100 * *
  An ability to interpret an assessment of cranial nerve function 93 NRC NE
  An ability to interpret an assessment of sedation levels (e.g. Ramsey Sedation Scale, Richmond Agitation-Sedation Scale) 100 * NRC
  An ability to perform a Glasgow Coma Score (GCS) 93 NRC NE
  An ability to perform a neurological examination of motor and sensory functions (e.g. light touch, pain, ASIA score) 98 * NRC
  An ability to perform an assessment of cranial nerve function 93 NE NE
  An ability to perform an assessment of sedation levels 98 NE NE
  Intra-cranial pressure (ICP) monitors (intra-parenchymal, intra-ventricular) and cerebral perfusion pressure (CPP) 52 74 * NRC
 Indices from blood gas measurement including
  A-a gradient 81 NE NE
  Base excess 76 * *
  HCO3 91 * *
  Lactate 87 NE NRC
  PaCO2 100 * *
  PaO2, SpO2, SaO2 100 * *
  PaO2/FiO2 ratio 100 * NE
  pH 98 * *
  Venous blood gas interpretation (including SvO2) 74 NRC NE
 (assess and interpret) Mechanical ventilation settings/measurements including
  Breath types (spontaneous, mandatory, assisted) 100 * *
  Maximum inspiratory pressure (MIP) measurements 63 72 NE NE
  Peak inspiratory pressure 93 * *
  Respiratory rate 100 * *
  Static and/or dynamic lung compliance measures 61 72 NE NE
  The level of FiO2 100 * *
  The level of PEEP 100 * *
  The level of PS 98 * *
  Tidal volume 100 * *
A physiotherapist can
 Perform and accurately interpret the results of common respiratory examinations including
  Auscultation 100 * *
  Observation of respiratory rate 100 * *
  Palpate the chest wall 94 * *
  Patterns of breathing 100 * *
 Assess
  The effectiveness/quality of a patient's cough (on or off mechanical ventilation) 96 * *
 Provide the following techniques, including an understanding of indications, contraindications, evidence for the technique, and progressions
  ACBT [breathing control, thoracic expansion and FET] 83 * *
  Assisted coughing - chest wall 85 * *
  Assisted coughing - subcostal thrusts for spinal cord injuries 54 74 * NRC
  Bed exercises (e.g. passive - active - resisted range of motion exercises) 100 * *
  Braces 74 NE NE
  Directed coughing/instructing the patient to cough effectively 96 * *
  Electrical stimulation (e.g. for isolated muscle activation to prevent muscle wasting, such as neuromuscular/functional electrical stimulation) 78 NE NE
  Humidification 76 * *
  Inexsufflator (Cough Assist) 65 70 NE *
  Inspiratory muscle training 78 NE NE
  Mobilization of non-ventilated patient (e.g. sitting on edge of bed, stand, hoist or slide transfer to chair, march on spot, walk, use of gait aids) 100 * *
  Mobilization of ventilated patient (e.g. sitting on edge of bed, stand, hoist or slide transfer to chair, march on spot, walk, use of gait aids) 98 * *
  NIV/BiPAP - for use during exercise or mobilization including initiation and titration of 69 70 NRC NE
  Patient positioning for prevention of pressure ulcers, management of tone, maintenance of musculoskeletal function 100 * *
  Patient positioning for respiratory care - including use of side lie, sitting upright, postural drainage (modified or head down tilt) 100 * *
  Patient prone positioning in severe respiratory failure/acute lung injury 87 NRC NRC
  Pursed lip breathing 98 * N/A
  Suction via a tracheal tube (Endotracheal tube, tracheostomy, minitracheostomy) 67 72 * *
  Supported coughing 98 * *
  Treadmill, cycle ergometry (e.g. Motomed) or stationary bike 87 NRC NE
A physiotherapist can
 Complete musculoskeletal and/or functional assessments including
  Ability to assess tone (e.g. utilizing a Modified Ashworth Scale) and reflexes 100 * NRC
  Deep vein thrombosis screening (i.e. color, temperature, touch, swelling, Homan's test) 93 * *
  Dynamometry 81 NRC NE
  Manual muscle testing (e.g. MRC scale) 98 * *
  Objective measures of cardiopulmonary exercise tolerance (e.g. 6-minute walk test; incremental shuttle walk test) 87 NRC NE
  Objective measures of physical function [e.g. the Physical Function ICU Test (PFIT), Timed Up and Go Test (TUG), 6MWT, De-Morton Mobility Index (DEMMI) ] 93 * NE
  Objective measures of quality of life (e.g. Short Form 36, EQ-5D, AQoL) 72 NE NE
  Peripheral edema 96 * *
  Range of motion 100 * *
 Appropriately
  Be aware of inotropes and implications for physiotherapy treatment 100 * N/A
  Be aware of sedation and implications for physiotherapy treatment 98 * N/A
  Liaise with medical/nursing staff to increase/decrease inotropes to achieve physiotherapy goals 85 * N/A
  Liaise with medical/nursing staff to increase/decrease sedation to achieve physiotherapy goals 94 * N/A
A physiotherapist can
  Assess and interpret ventilator waveforms 89 NE N/A
Determine the appropriateness of a patient for extubation 83 NRC NRC